Merrion Investment Management Co, LLC Vertex Pharmaceuticals Inc Transaction History
Merrion Investment Management Co, LLC
- $133 Million
- Q1 2025
A detailed history of Merrion Investment Management Co, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Merrion Investment Management Co, LLC holds 1,250 shares of VRTX stock, worth $554,425. This represents 0.45% of its overall portfolio holdings.
Number of Shares
1,250
Previous 1,005
24.38%
Holding current value
$554,425
Previous $404,000
50.0%
% of portfolio
0.45%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,833Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.45 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.45 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.23 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $114B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...